MedPath
Found 1 clinical trials|View Analysis
Sort by:

A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects

Phase 1
Completed
Conditions
Inflammatory Disease
Interventions
Drug: amilo-5MER
First Posted Date
2023-05-12
Last Posted Date
2023-05-12
Lead Sponsor
Galmed Pharmaceuticals Ltd
Target Recruit Count
55
Registration Number
NCT05857215
Locations
🇬🇧

Quotient Sciences, Mere Way, Ruddington, Nottingham, NG11 6JS, UK, Nottingham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath